It was launched in 2017. Simultaneously, the measles vaccine in the NIS (National Immunization Schedule) was replaced with MR vaccine. Hence, currently two doses of MR vaccines are given under the NIS.
1. At 9 to 12 months of age
2. At 16 to 24 months of age
It is a mass vaccination carried out as periodic events lasting 4 to 6 weeks each. Follow-up campaigns are also organized.
The purpose is to:
• Eliminate Measles, which is an extremely contagious disease with high mortality.
• Control (Reduce the incidence) of ‘Congenital Rubella Syndrome (CRS)
The age group targeted under these campaigns is 9 months to 15 years. The dose given during campaigns is over and above the routine 2 doses under the NIS, irrespective of the duration between the two.
Reference:
GOI 2017. Introduction of MR Vaccine; National Operational Guidelines: Ministry of Health and Family Welfare, New Delhi.